Cabozantinib Impurity 56
- CAS76274-09-4
- CatalogueRS-Z401KS3
- FormulaC14H12F2N2
- MW246.1
IN STOCK
On this page
Product identification
| Product name | Cabozantinib Impurity 56 |
|---|---|
| Catalogue No. | RS-Z401KS3 |
| CAS No. | 76274-09-4 |
| Molecular formula | C14H12F2N2 |
| Molecular weight | 246.1 |
| Availability | In stock— dispatched in about 1–2 weeks |
| Standard type | General Reference Standards |
| Drug substance | Cabozantinib |
| Also known as | CATO |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-Z401KS3 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
A certificate of analysis (COA) is issued for the lot you receive. It records the catalogue number
RS-Z401KS3 and the batch number, the tests performed, the
specification applied and the result obtained. A safety data sheet is supplied with the shipment.
Is the assigned value given on an “as is” basis?
Content and purity are stated per lot on the certificate of analysis, on an “as is” basis unless the certificate says otherwise. The analytical basis for the assigned value is stated on the certificate.
How should this material be stored?
Store as stated: Refer to the certificate of analysis (COA) supplied with each lot. Re-test before use beyond the retest date printed on the certificate.
Do you supply pack sizes other than those listed?
Pack sizes are confirmed with the quotation. Quantities beyond the standard pack sizes can be quoted — send the quantity you need with your enquiry.
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Cabozantinib
- General Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-Z401KS3
- Request a quotation for RS-Z401KS3
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Cabozantinib
All 98 further standards are listed here — every link is in the page, not loaded later.
-
Cabozantinib
IN STOCKRS-U063438 -
Cabozantinib Impurity B
IN STOCKRS-C046006 -
Cabozantinib Impurity C
IN STOCKRS-C046059 -
Cabozantinib Impurity F
IN STOCKRS-C046058 -
Cabozantinib Impurity G
IN STOCKRS-C046062 -
Cabozantinib Impurity O
IN STOCKRS-C046019 -
1,1-Cyclopropanedicarboxamide, N,N'-bis(4-chlorophenyl)-
CUSTOM SYNTHESISRS-U006A51 -
1-((3,4-Difluorophenyl)carbamoyl)cyclopropane-1-carboxylic Acid
IN STOCKRS-P006284 -
1-((4-Fluorophenyl)carbamoyl)cyclopropanecarbonyl chloride
BACK ORDERRS-U014491 -
1-(2-Amino-3,4-dimethoxyphenyl)ethan-1-one
IN STOCKRS-Z002SVC -
1-(ethoxycarbonyl)cyclopropane-1-carboxylic acid
IN STOCKRS-U008395 -
2-cyclopropyl-3-((4-fluorophenyl)amino)-3-oxopropanoic acid (Cabozantinib Impurity)
CUSTOM SYNTHESISRS-C1677033 -
3,4-Dimethoxyaniline Hydrochloride
CUSTOM SYNTHESISRS-P006920 -
4-(4-Aminophenoxy)-7-methoxyquinolin-6-ol
IN STOCKRS-Z401CPB -
4-Chloro-6,7-dihydroxyquinoline
CUSTOM SYNTHESISRS-U109005 -
4-chloro-7-methoxyquinolin-6-ol
IN STOCKRS-I002291 -
6,7-Dimethoxy-4-chloroquinoline
IN STOCKRS-U098229 -
6-chloro-1H-benzo[d][1,2,3]triazol-1-ol
IN STOCKRS-C046125 -
6-chlorocinnolin-4-ol
BACK ORDERRS-U063937 -
Cabozantinib Ethyl Ester Analog
BACK ORDERRS-C046040 -
Cabozantinib Hydrogen Sulfate
BACK ORDERRS-C046074 -
Cabozantinib Impurity BXB
CUSTOM SYNTHESISRS-C046061 -
Cabozantinib Impurity BXD
IN STOCKRS-C046017 -
Cabozantinib Impurity KG
IN STOCKRS-C046018 -
Cabozantinib Impurity KHLD
BACK ORDERRS-C046047 -
Cabozantinib S-malate
IN STOCKRS-I002024 -
Cabozantinib-d4 (Benzene Ring-d4)
BACK ORDERRS-I098317 -
Cabozantinib-d6 (1802168-46-2)
IN STOCKRS-C046070 -
Desquinolinylcabozantinib glucuronide
BACK ORDERRS-C046065 -
Diethyl cyclopropane-1,1-dicarboxylate
IN STOCKRS-U077155 -
Ethanone, 1,1'-cyclobutylidenebis-
IN STOCKRS-U095410 -
Formamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-
CUSTOM SYNTHESISRS-U101316 -
Methyl 1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxylate
CUSTOM SYNTHESISRS-P011297 -
N,N'-diphenylcyclobutane-1,1-dicarboxamide (Cabozantinib Impurity)
BACK ORDERRS-I014317 -
N,N'-Diphenylmalonamide
BACK ORDERRS-U042256 -
Cabozantinib Impurity 3
IN STOCKRS-C046063 -
Cabozantinib Impurity 25
IN STOCKRS-Z397LHK -
Cabozantinib Impurity 34
BACK ORDERRS-I001AAX -
Cabozantinib Impurity 45
IN STOCKRS-Z393QJN -
Cabozantinib Impurity 47
BACK ORDERRS-I001BS4 -
Cabozantinib Impurity 54
IN STOCKRS-C046032 -
Cabozantinib Impurity 60
IN STOCKRS-C046042 -
Cabozantinib Impurity 61
IN STOCKRS-C046008 -
Cabozantinib Impurity 63
IN STOCKRS-C046010 -
Cabozantinib Impurity 79
IN STOCKRS-C046052 -
Cabozantinib Impurity 86
CUSTOM SYNTHESISRS-C046025 -
Cabozantinib Impurity 97
IN STOCKRS-C046002 -
Cabozantinib Impurity 98
IN STOCKRS-C046011 -
Cabozantinib Impurity 99
BACK ORDERRS-C046014 -
Cabozantinib Impurity 101
CUSTOM SYNTHESISRS-C046022 -
Cabozantinib Impurity 102
BACK ORDERRS-C046023 -
Cabozantinib Impurity 103
IN STOCKRS-C046027 -
Cabozantinib Impurity 104
IN STOCKRS-C046031 -
Cabozantinib Impurity 105
CUSTOM SYNTHESISRS-C046037 -
Cabozantinib Impurity 106
IN STOCKRS-C046038 -
Cabozantinib Impurity 107
IN STOCKRS-C046051 -
Cabozantinib Impurity 108
IN STOCKRS-C046055 -
Cabozantinib Impurity 109
IN STOCKRS-C046057 -
Cabozantinib Impurity 110
CUSTOM SYNTHESISRS-C046066 -
Cabozantinib Impurity 112
IN STOCKRS-C046069 -
Cabozantinib Impurity 113
IN STOCKRS-C046071 -
Cabozantinib Impurity 114
CUSTOM SYNTHESISRS-C046072 -
Cabozantinib Impurity 116
IN STOCKRS-C046080 -
Cabozantinib Impurity 145
IN STOCKRS-C046001 -
Cabozantinib Impurity 146
IN STOCKRS-C046004 -
Cabozantinib Impurity 148
IN STOCKRS-C046007 -
Cabozantinib Impurity 149
BACK ORDERRS-C046009 -
Cabozantinib Impurity 150
CUSTOM SYNTHESISRS-C046012 -
Cabozantinib Impurity 151
BACK ORDERRS-C046013 -
Cabozantinib Impurity 152
BACK ORDERRS-C046015 -
Cabozantinib Impurity 153
IN STOCKRS-C046016 -
Cabozantinib Impurity 154
IN STOCKRS-C046020 -
Cabozantinib Impurity 155
IN STOCKRS-C046024 -
Cabozantinib Impurity 156
IN STOCKRS-C046026 -
Cabozantinib Impurity 157
BACK ORDERRS-C046028 -
Cabozantinib Impurity 158
IN STOCKRS-C046029 -
Cabozantinib Impurity 159
IN STOCKRS-C046030 -
Cabozantinib Impurity 160
IN STOCKRS-C046033 -
Cabozantinib Impurity 161
CUSTOM SYNTHESISRS-C046034 -
Cabozantinib Impurity 162
IN STOCKRS-C046035 -
Cabozantinib Impurity 163
IN STOCKRS-C046036 -
Cabozantinib Impurity 164
IN STOCKRS-C046039 -
Cabozantinib Impurity 165
BACK ORDERRS-C046041 -
Cabozantinib Impurity 166
IN STOCKRS-C046043 -
Cabozantinib Impurity 167
IN STOCKRS-C046044 -
Cabozantinib Impurity 168
IN STOCKRS-C046045 -
Cabozantinib Impurity 169
IN STOCKRS-C046046 -
Cabozantinib Impurity 170
BACK ORDERRS-C046048 -
Cabozantinib Impurity 171
BACK ORDERRS-C046049 -
Cabozantinib Impurity 172
IN STOCKRS-C046050 -
Cabozantinib Impurity 173
IN STOCKRS-C046053 -
Cabozantinib Impurity 174
IN STOCKRS-C046054 -
Cabozantinib Impurity 175
IN STOCKRS-C046056 -
Cabozantinib Impurity 176
IN STOCKRS-C046060 -
Cabozantinib Impurity 177
IN STOCKRS-C046064 -
Cabozantinib Impurity 178
CUSTOM SYNTHESISRS-C046068 -
Cabozantinib Impurity 179
IN STOCKRS-C046073 -
Cabozantinib Impurity 234
IN STOCKRS-C046077
![Chemical structure of 6-chloro-1H-benzo[d][1,2,3]triazol-1-ol](/structures/w4/TZCYLJGNWDVJRA-UHFFFAOYSA-N.webp?v=8)
![Chemical structure of Formamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-](/structures/w4/BMJSMJQAXGYOKO-UHFFFAOYSA-N.webp?v=8)
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.